Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis. (2014)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/nature13862

PubMed Identifier: 25337873

Publication URI: http://europepmc.org/abstract/MED/25337873

Type: Journal Article/Review

Volume: 515

Parent Publication: Nature

Issue: 7525

ISSN: 0028-0836